These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28875858)

  • 1. Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions.
    Duffy SS; Lees JG; Perera CJ; Moalem-Taylor G
    Med Chem; 2018 Feb; 14(2):106-119. PubMed ID: 28875858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
    Khan N; Woodruff TM; Smith MT
    Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis.
    Shkodina AD; Bardhan M; Chopra H; Anyagwa OE; Pinchuk VA; Hryn KV; Kryvchun AM; Boiko DI; Suresh V; Verma A; Delva MY
    CNS Drugs; 2024 Mar; 38(3):205-224. PubMed ID: 38421578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models.
    Khan N; Smith MT
    Inflammopharmacology; 2014 Feb; 22(1):1-22. PubMed ID: 24234347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous).
    Attal N; Mazaltarine G; Perrouin-Verbe B; Albert T;
    Ann Phys Rehabil Med; 2009 Mar; 52(2):124-41. PubMed ID: 19909703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral sensory neuron injury contributes to neuropathic pain in experimental autoimmune encephalomyelitis.
    Wang IC; Chung CY; Liao F; Chen CC; Lee CH
    Sci Rep; 2017 Feb; 7():42304. PubMed ID: 28181561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):71-8. PubMed ID: 20021340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the pharmacological management of pain in patients with multiple sclerosis.
    Chisari CG; Sgarlata E; Arena S; D'Amico E; Toscano S; Patti F
    Expert Opin Pharmacother; 2020 Dec; 21(18):2249-2263. PubMed ID: 32343626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain.
    Khan N; Kuo A; Brockman DA; Cooper MA; Smith MT
    Inflammopharmacology; 2018 Feb; 26(1):77-86. PubMed ID: 28965161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Truong JJ; Kerr BJ
    Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes.
    Dutra RC; Bento AF; Leite DF; Manjavachi MN; Marcon R; Bicca MA; Pesquero JB; Calixto JB
    Neurobiol Dis; 2013 Jun; 54():82-93. PubMed ID: 23454198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of the RNA-binding protein HuR attenuates hyperalgesia and motor disability in experimental autoimmune encephalomyelitis.
    Sanna MD; Quattrone A; Galeotti N
    Neuropharmacology; 2017 Sep; 123():116-125. PubMed ID: 28599923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathic Pain Secondary to Multiple Sclerosis: A Narrative Review.
    McBenedict B; Goh KS; Yau RCC; Elamin S; Yusuf WH; Verly G; Thomas A; Alphonse B; Ouabicha K; Valentim G; Hauwanga WN; Lima Pessôa B
    Cureus; 2024 Jun; 16(6):e61587. PubMed ID: 38962595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of pharmacological pain management in multiple sclerosis.
    Jawahar R; Oh U; Yang S; Lapane KL
    Drugs; 2013 Oct; 73(15):1711-22. PubMed ID: 24085618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical moringin-cream relieves neuropathic pain by suppression of inflammatory pathway and voltage-gated ion channels in murine model of multiple sclerosis.
    Giacoppo S; Iori R; Bramanti P; Mazzon E
    Mol Pain; 2017; 13():1744806917724318. PubMed ID: 28741431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFNS guidelines on pharmacological treatment of neuropathic pain.
    Attal N; Cruccu G; Haanpää M; Hansson P; Jensen TS; Nurmikko T; Sampaio C; Sindrup S; Wiffen P;
    Eur J Neurol; 2006 Nov; 13(11):1153-69. PubMed ID: 17038030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathic pain of peripheral origin: advances in pharmacologic treatment.
    Galer BS
    Neurology; 1995 Dec; 45(12 Suppl 9):S17-25; discussion S35-6. PubMed ID: 8538882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the Treatment of Neuropathic Pain.
    Xu L; Zhang Y; Huang Y
    Adv Exp Med Biol; 2016; 904():117-29. PubMed ID: 26900067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological treatment of neuropathic pain].
    Ollat H
    Rev Neurol (Paris); 1992; 148(8-9):521-31. PubMed ID: 1337388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Painful peripheral neuropathy and its nonsurgical treatment.
    Wolfe GI; Trivedi JR
    Muscle Nerve; 2004 Jul; 30(1):3-19. PubMed ID: 15221874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.